Current status of acute ischemic stroke management in Iran: Findings from a single-center study.

IF 2.3 Q3 EMERGENCY MEDICINE

Turkish Journal of Emergency Medicine Pub Date : 2022-09-30 eCollection Date: 2022-10-01 DOI:10.4103/2452-2473.357344

Hesamedin Askari-Majdabadi, Zahra Basereh, Amin Soheili, Kelly Powers, Mohsen Soleimani, Majid Mirmohammdkhani, Tahoura Afshari Saleh

{"title":"Current status of acute ischemic stroke management in Iran: Findings from a single-center study.","authors":"Hesamedin Askari-Majdabadi, Zahra Basereh, Amin Soheili, Kelly Powers, Mohsen Soleimani, Majid Mirmohammdkhani, Tahoura Afshari Saleh","doi":"10.4103/2452-2473.357344","DOIUrl":null,"url":null,"abstract":"Objectives: This study investigated the current status of acute ischemic stroke (AIS) management in an Iranian emergency department (ED).Methods: A descriptive study using a retrospective chart review was conducted on medical records of 270 patients with AIS who presented to the ED of a tertiary university hospital in the northeast of Iran from March 22 to September 22, 2019. The steps of this review process included instrument identification, medical records retrieval, data extraction, and data verification.Results: Of patients with AIS, 88.9% (n = 240) did not receive stroke code activation. For the 11.1% of patients (n = 30) who received activation, 7% of codes (n = 19) were canceled by the acute stroke team and IV recombinant tissue plasminogen activator (r-tPA) was only administered for 4.1% of patients (n = 11). ED arrival outside 4.5 h from symptom onset was the main barrier to IV r-tPA administration for 83.8% of potentially eligible patients with AIS (n = 217). The median door-to-needle time was 70 min (interquartile range: 47-90 min).Conclusions: There was a better clinical performance in terms of critical time goals in potentially eligible patients with AIS if managed with stroke team activation compared to no stroke team activation.","PeriodicalId":46536,"journal":{"name":"Turkish Journal of Emergency Medicine","volume":" ","pages":"213-220"},"PeriodicalIF":2.3000,"publicationDate":"2022-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/ea/TJEM-22-213.PMC9639744.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Emergency Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/2452-2473.357344","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}

引用次数: 1

Abstract

Objectives: This study investigated the current status of acute ischemic stroke (AIS) management in an Iranian emergency department (ED).

Methods: A descriptive study using a retrospective chart review was conducted on medical records of 270 patients with AIS who presented to the ED of a tertiary university hospital in the northeast of Iran from March 22 to September 22, 2019. The steps of this review process included instrument identification, medical records retrieval, data extraction, and data verification.

Results: Of patients with AIS, 88.9% (n = 240) did not receive stroke code activation. For the 11.1% of patients (n = 30) who received activation, 7% of codes (n = 19) were canceled by the acute stroke team and IV recombinant tissue plasminogen activator (r-tPA) was only administered for 4.1% of patients (n = 11). ED arrival outside 4.5 h from symptom onset was the main barrier to IV r-tPA administration for 83.8% of potentially eligible patients with AIS (n = 217). The median door-to-needle time was 70 min (interquartile range: 47-90 min).

Conclusions: There was a better clinical performance in terms of critical time goals in potentially eligible patients with AIS if managed with stroke team activation compared to no stroke team activation.

Abstract Image

查看原文本刊更多论文

伊朗急性缺血性脑卒中管理现状:一项单中心研究的结果

目的:本研究调查了伊朗急诊科(ED)急性缺血性卒中(AIS)管理的现状。方法:对2019年3月22日至9月22日在伊朗东北部某三级大学医院急诊科就诊的270例AIS患者的病历进行回顾性图表复习的描述性研究。该审查过程的步骤包括仪器识别、医疗记录检索、数据提取和数据验证。结果:在AIS患者中，88.9% (n = 240)未接受脑卒中代码激活。在接受激活的11.1%的患者(n = 30)中，7%的代码(n = 19)被急性卒中团队取消，只有4.1%的患者(n = 11)使用了重组组织型纤溶酶原激活剂(r-tPA)。83.8%的潜在符合条件的AIS患者(n = 217)在症状出现后4.5小时内出现ED是静脉注射r-tPA的主要障碍。门到针的中位时间为70 min(四分位数间距为47 ~ 90 min)。结论:与没有卒中团队激活相比，卒中团队激活管理的潜在符合条件的AIS患者在关键时间目标方面有更好的临床表现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Turkish Journal of Emergency Medicine EMERGENCY MEDICINE-

CiteScore

1.70

自引率

0.00%

发文量

审稿时长

22 weeks

期刊介绍： The Turkish Journal of Emergency Medicine (Turk J Emerg Med) is an International, peer-reviewed, open-access journal that publishes clinical and experimental trials, case reports, invited reviews, case images, letters to the Editor, and interesting research conducted in all fields of Emergency Medicine. The Journal is the official scientific publication of the Emergency Medicine Association of Turkey (EMAT) and is printed four times a year, in January, April, July and October. The language of the journal is English. The Journal is based on independent and unbiased double-blinded peer-reviewed principles. Only unpublished papers that are not under review for publication elsewhere can be submitted. The authors are responsible for the scientific content of the material to be published. The Turkish Journal of Emergency Medicine reserves the right to request any research materials on which the paper is based. The Editorial Board of the Turkish Journal of Emergency Medicine and the Publisher adheres to the principles of the International Council of Medical Journal Editors, the World Association of Medical Editors, the Council of Science Editors, the Committee on Publication Ethics, the US National Library of Medicine, the US Office of Research Integrity, the European Association of Science Editors, and the International Society of Managing and Technical Editors.